Steeve Néron
Corporate Officer/Principal chez TETRA BIO-PHARMA INC.
Profil
Steeve Néron is currently the Director at TALLC Corp., Inc. and the Chief Commercial Officer at Tetra Bio-Pharma, Inc. He previously worked as the Senior Portfolio Manager at Valeant Canada Ltd.
from 2013 to 2018.
Mr. Néron completed his undergraduate degree from Université du Québec à Chicoutimi in 1986.
Postes actifs de Steeve Néron
Sociétés | Poste | Début |
---|---|---|
TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 17/09/2020 |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Steeve Néron
Sociétés | Poste | Fin |
---|---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Corporate Officer/Principal | 01/02/2018 |
Formation de Steeve Néron
Université du Québec à Chicoutimi | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
TETRA BIO-PHARMA INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |